Dextran sulphates protect porcine arterial endothelial cells from free radical injury.
1. The ability of dextran sulphate to protect cultured porcine arterial endothelial cells injured by addition of xanthine and xanthine oxidase (X/XO) or hydrogen peroxide to cell medium was examined using a variety of drug preparations. Cell damage was assessed by determining cell viability (by trypan blue exclusion) and release of lactate dehydrogenase into the medium. 2. Dextran sulphates of average molecular weight (M(r)) 5000, 8000 (hydrogenated or unhydrogenated) at 0.05, 0.5, 5 and 50 micrograms ml-1 medium, added 24 h prior to X/XO, protected cells, whereas dextran sulphate M(r) 500,000 was protective only at 0.5 microgram ml-1. 3. None of the dextran sulphates used showed any toxic effect on cells in concentrations up to 500 micrograms ml-1 medium. 4. When the duration of pretreatment with dextran sulphate M(r) 8000 was varied, 6 h was required for a protective effect on cells damaged by X/XO, which was enhanced with durations of 16 and 24 h. 5. Dextran sulphates had a similar protective effect on cells damaged by hydrogen peroxide. 6. This study suggest that dextran sulphates may prevent conditions resulting from free radical injury.
Hiebert
L M
LM
Department of Veterinary Physiological Sciences, University of Saskatchewan, Saskatoon, Canada.
Liu
J M
JM
D000818:Animals; D001011:Aorta / Q000166:cytology / Q000187:drug effects; D002478:Cells, Cultured; D016264:Dextran Sulfate / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000187:drug effects*; D005609:Free Radicals / Q000037:antagonists & inhibitors* / Q000633:toxicity; D006861:Hydrogen Peroxide / Q000037:antagonists & inhibitors; D013552:Swine; D019820:Xanthine; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors; D014970:Xanthines / Q000037:antagonists & inhibitors
D005609:Free Radicals; D014970:Xanthines; D019820:Xanthine; D016264:Dextran Sulfate; D006861:Hydrogen Peroxide; D014969:Xanthine Oxidase